Genetic variation associated with preterm birth in African-American women

American Journal of Obstetrics and Gynecology

Volumn 215, Issue 2, 2016, Pages 235.e1-235.e8

  Frey, Heather A ^a   Stout, Molly J ^b   Pearson, Laurel N ^c   Tuuli, Methodius G ^b   Cahill, Alison G ^b   Strauss, Jerome F ^e   Gomez, Luis M ^f   Parry, Samuel ^d   Allsworth, Jenifer E ^g   Macones, George A ^b  

^a OHIO STATE UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c PENNSYLVANIA STATE UNIVERSITY   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^g UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

Author keywords

genetics; inflammation; preterm birth

Indexed keywords

COMPLEMENTARY RNA; DNA; FMS RELATED TYROSINE KINASE 1; GELATINASE A; INTERLEUKIN 16; INTERSTITIAL COLLAGENASE; LEUKEMIA INHIBITORY FACTOR RECEPTOR ANTISENSE RNA 1; PROTEIN KINASE C ALPHA; PROTEIN TYROSINE KINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 2; UNCLASSIFIED DRUG; PRKCA PROTEIN, HUMAN; TIMP2 PROTEIN, HUMAN;

ADULT; AFRICAN AMERICAN; ALLELE; ANCESTRY GROUP; ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; FEMALE; GENETIC ASSOCIATION; GENOTYPE; GESTATIONAL AGE; HIGH RISK PREGNANCY; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MICROARRAY ANALYSIS; PATHOGENESIS; PREMATURE LABOR; PRENATAL CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SECONDARY ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; TERM BIRTH; GENETIC PREDISPOSITION; GENETICS; PREGNANCY; PREMATURITY; RANDOMIZED CONTROLLED TRIAL; YOUNG ADULT;

ADULT; AFRICAN AMERICANS; ALLELES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERLEUKIN-16; MATRIX METALLOPROTEINASE 2; OBSTETRIC LABOR, PREMATURE; POLYMORPHISM, SINGLE NUCLEOTIDE; PREGNANCY; PREMATURE BIRTH; PROTEIN KINASE C-ALPHA; TISSUE INHIBITOR OF METALLOPROTEINASE-2; YOUNG ADULT;

EID: 84963788650     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2016.03.008     Document Type: Article

References (61)

1. 1 Saigal, S., Doyle, L.W., An overview of mortality and sequelae of preterm birth from infancy to adulthood. Lancet 371 (2008), 261–269.
2. 2 McIntire, D.D., Leveno, K.J., Neonatal mortality and morbidity rates in late preterm births compared with births at term. Obstet Gynecol 111 (2008), 35–41.
3. 3 Martin, J.A., Hamilton, B.E., Ventura, S.J., Osterman, M., Wilson, E.C., Mathews, T.J., Births: final data for 2010. Natl Vital Stat Rep 61 (2012), 1–21.
4. 4 Treloar, S.A., Macones, G.A., Mitchell, L.E., Martin, N.G., Genetic influences on premature parturition in an Australian twin sample. Twin Res 3 (2000), 80–82.
5. 5 Clausson, B., Lichtenstein, P., Cnattingius, S., Genetic influence on birthweight and gestational length determined by studies in offspring of twins. BJOG 107 (2000), 375–381.
6. 6 Winkvist, A., Mogren, I., Hogberg, U., Familial patterns in birth characteristics: impact on individual and population risks. Int J Epidemiol 27 (1998), 248–254.
7. 7 Porter, T.F., Fraser, A.M., Hunter, C.Y., Ward, R.H., Varner, M.W., The risk of preterm birth across generations. Obstet Gynecol 90 (1997), 63–67.
8. 8 Mercer, B.M., Goldenberg, R.L., Das, A., et al. The preterm prediction study: a clinical risk assessment system. Am J Obstet Gynecol 174 (1996), 1885–1893 discussion 1893-95.
9. 9 Tsai, H.J., Yu, Y., Zhang, S., et al. Association of genetic ancestry with preterm delivery and related traits among African American mothers. Am J Obstet Gynecol 201 (2009), 94.e9–94.e10.
10. 10 Menon, R., Pearce, B., Velez, D.R., et al. Racial disparity in pathophysiologic pathways of preterm birth based on genetic variants. Reprod Biol Endocrinol, 7, 2009, 62.
11. 11 Manuck, T.A., Lai, Y., Meis, P.J., et al. Admixture mapping to identify spontaneous preterm birth susceptibility loci in African Americans. Obstet Gynecol 117 (2011), 1078–1084.
12. 12 Fortunato, S.J., Menon, R., Velez, D.R., Thorsen, P., Williams, S.M., Racial disparity in maternal-fetal genetic epistasis in spontaneous preterm birth. Am J Obstet Gynecol 198 (2008), 666.e1–666.e9.
13. 13 Anum, E.A., Springel, E.H., Shriver, M.D., Strauss, J.F. 3rd, Genetic contributions to disparities in preterm birth. Pediatr Res 65 (2009), 1–9.
14. 14 Baggia, S., Gravett, M.G., Witkin, S.S., Haluska, G.J., Novy, M.J., Interleukin-1 beta intra-amniotic infusion induces tumor necrosis factor-alpha, prostaglandin production, and preterm contractions in pregnant rhesus monkeys. J Soc Gynecol Investig 3 (1996), 121–126.
15. 15 Fortunato, S.J., Menon, R., Lombardi, S.J., Role of tumor necrosis factor-alpha in the premature rupture of membranes and preterm labor pathways. Am J Obstet Gynecol 187 (2002), 1159–1162.
16. 16 Gervasi, M.T., Romero, R., Bracalente, G., et al. Midtrimester amniotic fluid concentrations of interleukin-6 and interferon-gamma-inducible protein-10: evidence for heterogeneity of intra-amniotic inflammation and associations with spontaneous early (<32 weeks) and late (>32 weeks) preterm delivery. J Perinat Med 40 (2012), 329–343.
17. 17 Maymon, E., Ghezzi, F., Edwin, S.S., et al. The tumor necrosis factor alpha and its soluble receptor profile in term and preterm parturition. Am J Obstet Gynecol 181 (1999), 1142–1148.
18. 18 Romero, R., Mazor, M., Brandt, F., et al. Interleukin-1 alpha and interleukin-1 beta in preterm and term human parturition. Am J Reprod Immunol 27 (1992), 117–123.
19. 19 Romero, R., Mazor, M., Tartakovsky, B., Systemic administration of interleukin-1 induces preterm parturition in mice. Am J Obstet Gynecol 165:4 Pt 1 (1991), 969–971.
20. 20 Sadowsky, D.W., Adams, K.M., Gravett, M.G., Witkin, S.S., Novy, M.J., Preterm labor is induced by intraamniotic infusions of interleukin-1beta and tumor necrosis factor-alpha but not by interleukin-6 or interleukin-8 in a nonhuman primate model. Am J Obstet Gynecol 195 (2006), 1578–1589.
21. 21 Tanaka, Y., Narahara, H., Takai, N., Yoshimatsu, J., Anai, T., Miyakawa, I., Interleukin-1 beta and interleukin-8 in cervicovaginal fluid during pregnancy. Am J Obstet Gynecol 179:3 Pt 1 (1998), 644–649.
22. 22 Wenstrom, K.D., Andrews, W.W., Hauth, J.C., Goldenberg, R.L., DuBard, M.B., Cliver, S.P., Elevated second-trimester amniotic fluid interleukin-6 levels predict preterm delivery. Am J Obstet Gynecol 178 (1998), 546–550.
23. 23 Romero, R., Espinoza, J., Goncalves, L.F., Kusanovic, J.P., Friel, L., Hassan, S., The role of inflammation and infection in preterm birth. Semin Reprod Med 25 (2007), 21–39.
24. 24 Velez, D.R., Fortunato, S.J., Thorsen, P., Lombardi, S.J., Williams, S.M., Menon, R., Preterm birth in Caucasians is associated with coagulation and inflammation pathway gene variants. PloS One, 3, 2008, e3283.
25. 25 Romero, R., Friel, L.A., Velez Edwards, D.R., et al. A genetic association study of maternal and fetal candidate genes that predispose to preterm prelabor rupture of membranes (PROM). Am J Obstet Gynecol 203 (2010), 361.e1–361.e30.
26. 26 Murtha, A.P., Nieves, A., Hauser, E.R., et al. Association of maternal IL-1 receptor antagonist intron 2 gene polymorphism and preterm birth. Am J Obstet Gynecol 195 (2006), 1249–1253.
27. 27 Harper, M., Zheng, S.L., Thom, E., et al. Cytokine gene polymorphisms and length of gestation. Obstet Gynecol 117 (2011), 125–130.
28. 28 Gomez, L.M., Sammel, M.D., Appleby, D.H., et al. Evidence of a gene-environment interaction that predisposes to spontaneous preterm birth: a role for asymptomatic bacterial vaginosis and DNA variants in genes that control the inflammatory response. Am J Obstet Gynecol 202 (2010), 386.e1–386.e6.
29. 29 Roberts, A.K., Monzon-Bordonaba, F., Van Deerlin, P.G., et al. Association of polymorphism within the promoter of the tumor necrosis factor alpha gene with increased risk of preterm premature rupture of the fetal membranes. Am J Obstet Gynecol 180 (1999), 1297–1302.
30. 30 Macones, G.A., Parry, S., Elkousy, M., Clothier, B., Ural, S.H., Strauss, J.F. 3rd, A polymorphism in the promoter region of TNF and bacterial vaginosis: preliminary evidence of gene-environment interaction in the etiology of spontaneous preterm birth. Am J Obstet Gynecol 190 (2004), 1504–1508.
31. 31 Simhan, H.N., Krohn, M.A., Roberts, J.M., Zeevi, A., Caritis, S.N., Interleukin-6 promoter -174 polymorphism and spontaneous preterm birth. Am J Obstet Gynecol 189 (2003), 915–918.
32. 32 Haataja, R., Karjalainen, M.K., Luukkonen, A., et al. Mapping a new spontaneous preterm birth susceptibility gene, IGF1R, using linkage, haplotype sharing, and association analysis. PLoS Genet, 7, 2011, e1001293.
33. 33 Macones, G.A., Parry, S., Nelson, D.B., et al. Treatment of localized periodontal disease in pregnancy does not reduce the occurrence of preterm birth: results from the Periodontal Infections and Prematurity Study (PIPS). Am J Obstet Gynecol 202 (2010), 147.e1–147.e8.
34. 34 Srinivas, S.K., Sammel, M.D., Stamilio, D.M., et al. Periodontal disease and adverse pregnancy outcomes: is there an association?. Am J Obstet Gynecol 200 (2009), 497.e1–497.e8.
35. 35 International HapMap Consortium. The International HapMap Project. Nature 426 (2003), 789–796.
36. 36 Chang, C.C., Chow, C.C., Tellier, L.C., Vattikuti, S., Purcell, S.M., Lee, J.J., Second-generation PLINK: rising to the challenge of larger and richer datasets. GigaScience, 4, 2015, 7.
37. 37 Purcell, S., Neale, B., Todd-Brown, K., et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Obstet Gynecol 81 (2007), 559–575.
38. 38 Lunetta, K.L., Genetic association studies. Circulation 118 (2008), 96–101.
39. 39 Menon, R., Fortunato, S.J., Thorsen, P., Williams, S., Genetic associations in preterm birth: a primer of marker selection, study design, and data analysis. J Soc Gynecol Investig, 13, 2006, 531541.
40. 40 Hoggart, C.J., Parra, E.J., Shriver, M.D., et al. Control of confounding of genetic associations in stratified populations. Am J Hum Genet 72 (2003), 1492–1504.
41. 41 Hoggart, C.J., Shriver, M.D., Kittles, R.A., Clayton, D.G., McKeigue, P.M., Design and analysis of admixture mapping studies. Am J Hum Genet 74 (2004), 965–978.
42. 42 Nakashima, S., Protein kinase C alpha (PKC alpha): regulation and biological function. J Biochem 132 (2002), 669–675.
43. 43 Braz, J.C., Gregory, K., Pathak, A., et al. PKC-alpha regulates cardiac contractility and propensity toward heart failure. Nat Med 10 (2004), 248–254.
44. 44 Hambleton, M., Hahn, H., Pleger, S.T., et al. Pharmacological- and gene therapy-based inhibition of protein kinase Calpha/beta enhances cardiac contractility and attenuates heart failure. Circulation 114 (2006), 574–582.
45. 45 Lee, Y.H., Kim, I., Laporte, R., Walsh, M.P., Morgan, K.G., Isozyme-specific inhibitors of protein kinase C translocation: effects on contractility of single permeabilized vascular muscle cells of the ferret. J Physiol 517:Pt 3 (1999), 709–720.
46. 46 Patil, S.B., Pawar, M.D., Bitar, K.N., Direct association and translocation of PKC-alpha with calponin. Am J Physiol Gastrointest Liver Physiol 286 (2004), G954–G963.
47. 47 Somara, S., Pang, H., Bitar, K.N., Agonist-induced association of tropomyosin with protein kinase C alpha in colonic smooth muscle. Am J Physiol Gastrointest Liver Physiol 288 (2005), G268–G276.
48. 48 Fomin, V.P., Kronbergs, A., Gunst, S., et al. Role of protein kinase C alpha in regulation of [Ca2+](I) and force in human myometrium. Reprod Sci 16 (2009), 71–79.
49. 49 Jofre, N.M., Delpiano, A.M., Cuello, M.A., Poblete, J.A., Vargas, P.A., Carvajal, J.A., Isoform alpha of PKC may contribute to the maintenance of pregnancy myometrial quiescence in humans. Reprod Sci 20 (2013), 69–77.
50. 50 Athayde, N., Romero, R., Maymon, E., et al. Interleukin 16 in pregnancy, parturition, rupture of fetal membranes, and microbial invasion of the amniotic cavity. Am J Obstet Gynecol 182:1 Pt 1 (2000), 135–141.
51. 51 Hsu, T.Y., Lin, H., Lan, K.C., et al. High interleukin-16 concentrations in the early second trimester amniotic fluid: an independent predictive marker for preterm birth. J Matern Fetal Neonatal Med 26 (2013), 285–289.
52. 52 Bischof, P., Martelli, M., Campana, A., Itoh, Y., Ogata, Y., Nagase, H., Importance of matrix metalloproteinases in human trophoblast invasion. Early Pregnancy 1 (1995), 263–269.
53. 53 Isaka, K., Usuda, S., Ito, H., et al. Expression and activity of matrix metalloproteinase 2 and 9 in human trophoblasts. Placenta 24 (2003), 53–64.
54. 54 Maymon, E., Romero, R., Pacora, P., et al. Evidence of in vivo differential bioavailability of the active forms of matrix metalloproteinases 9 and 2 in partuition, spontaneous rupture of membranes, and intra-amniotic infection. Am J Obstet Gynecol 183 (2000), 887–894.
55. 55 Koucky, M., Germanova, A., Kalousova, M., et al. Low maternal serum matrix metalloproteinase (MMP)-2 concentrations are associated with preterm labor and fetal inflammatory response. J Perinat Med 38 (2010), 589–596.
56. 56 Romero, R., Velez Edwards, D.R., Kusanovic, J.P., et al. Identification of fetal and maternal single nucleotide polymorphisms in candidate genes that predispose to spontaneous preterm labor with intact membranes. Am J Obstet Gynecol 202 (2010), 431.e1–431.e34.
57. 57 Maymon, E., Romero, R., Pacora, P., et al. Evidence for the participation of interstitial collagenase (matrix metalloproteinase 1) in preterm premature rupture of membranes. Am J Obstet Gynecol 183 (2000), 914–920.
58. 58 Fujimoto, T., Parry, S., Urbanek, M., et al. A single nucleotide polymorphism in the matrix metalloproteinase-1 (MMP-1) promoter influences amnion cell MMP-1 expression and risk for pretrm pretmature rupture of the fetal membranes. J Biol Chem 277 (2002), 6296–6302.
59. 59 Kleinrouweler, C.E., Wiegerinck, M.M., Ris-Stalpers, C., et al. Accuracy of circulating placental growth factor, vascular endothelial growth factor, soluble fms-like tyrosine kinase 1 and soluble endoglin in the prediction of preeclampsia: a systematic review and meta-analysis. BJOG 119 (2012), 778–787.
60. 60 Straughen, J.K., Kumar, P., Misra, V., The effect of maternal soluble FMS-like tyrosine kinase 1 during pregnancy on risk of preterm delivery. J Matern Fetal Neonatal Med 25 (2012), 1879–1883.
61. 61 Lass, A., Weiser, W., Mufano, A., Loumaye, E., Leukemia inhibitory factor in reproduction. Fertil Steril 76 (2001), 1091–1096.